Using patented purification methods and a community-first growth strategy, the Root Brands is redefining what it means to ...

Students at centers like BioTC in OKC and other locations are training to step into jobs that didn’t even exist a decade ago ...

Veteran academic to collaborate with Chinese scientists to develop next-gen cancer therapies using vaccine tech for tumour ...

ATGC Biotech, a leading Indian innovator in pheromone and semiochemical-based crop protection, on Tuesday announced the ...

Butani and Yu were two of the 43 recipients of the 2025 Marshall Scholarship, which funds two years of study in the United ...

Spyre Therapeutics (SYRE) has strong technical momentum and is trading at a new 52 week high. SYRE maintains a 100% “Buy” ...

India continues to face an alarming rise in air- and water-borne diseases, driven by rapid urbanization, population growth, ...

Daniel Yu, of New York City, is majoring in African American studies and pursuing minors in English and in gender and ...

India’s bioeconomy, which includes biotech, pharma and agriculture, officially valued at 165 billion dollars in 2024, was expected to reach $300 billion by 2030, Prof. Sudhir Kumar Sopory, President ...

Innovation cycles are shifting at a remarkable pace. Artificial intelligence, biotechnology and clean energy systems now influence how nations design public pol ...

Mangaluru stands as a premier institution of higher learning, distinguished by a 146-year Jesuit legacy that blends academic ...

Imviva Biotech, a clinical-stage biotechnology company developing next-generation allogeneic CAR-T cell therapies, today presented clinical data for CTD402, its investigational allogeneic anti-CD7 CAR ...